Genetics of iron regulation and the possible role of iron in Parkinson's disease

被引:90
作者
Rhodes, Shannon L. [1 ]
Ritz, Beate [2 ]
机构
[1] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA
关键词
Parkinson's disease; Iron regulatory proteins; Genetics; Pathogenesis;
D O I
10.1016/j.nbd.2008.07.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is acknowledged as the second most common neurodegenerative disorder after Alzheimer's Disease. Older age may be the only unequivocal risk factor for PD although the male to female ratio is consistently greater than 1 in populations of European ancestry. Characteristic features of PD include dopaminergic neuron death in the substantia nigra (SN) pars compacta, accumulation of alpha-synuclein inclusions known as Lewy bodies in the SN, and brain iron accumulation beyond that observed in non-PD brains of a similar age. In this review article, we will provide an overview of human and animal studies investigating the contributions of iron in PD, a summary of human studies of iron-related genes in PD, a review of the literature on the genetics of iron metabolism, and some hypotheses on possible roles for iron in the pathogenic processes of PD including potential interactions between iron and other factors associated with Parkinson's disease. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:183 / 195
页数:13
相关论文
共 209 条
  • [21] Extensive axonal Lewy neurites in Parkinson's disease:: a novel pathological feature revealed by α-synuclein immunocytochemistry
    Braak, H
    Sandmann-Keil, D
    Gai, WP
    Braak, E
    [J]. NEUROSCIENCE LETTERS, 1999, 265 (01) : 67 - 69
  • [22] Electrochemical investigation into the redox activity of Fe(II)/Fe(III) in the presence of nicotine and possible relations to neurodegenerative diseases
    Bridge, MH
    Williams, E
    Lyons, MEG
    Tipton, KF
    Linert, W
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2004, 1690 (01): : 77 - 84
  • [23] Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis
    Bridle, KR
    Frazer, DM
    Wilkins, SJ
    Dixon, JL
    Purdie, DM
    Crawford, DHG
    Subramaniam, VN
    Powell, LW
    Anderson, GJ
    Ramm, GA
    [J]. LANCET, 2003, 361 (9358) : 669 - 673
  • [24] The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients
    Buchanan, DD
    Silburn, PA
    Chalk, JB
    Le Couteur, DG
    Mellick, GD
    [J]. NEUROSCIENCE LETTERS, 2002, 327 (02) : 91 - 94
  • [25] Burdo JR, 2001, J NEUROSCI RES, V66, P1198, DOI 10.1002/jnr.1256.abs
  • [26] Burn John, 2006, Semin Pediatr Neurol, V13, P176
  • [27] Casiday R, 2000, IRON BIOL STUDY IRON
  • [28] Screening of ferritin light polypeptide 460-461InsA mutation in Parkinson's disease patients in North America
    Chen, R
    Langston, JW
    Chan, P
    [J]. NEUROSCIENCE LETTERS, 2002, 335 (02) : 144 - 146
  • [29] TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis
    Chen, TT
    Li, L
    Chung, DH
    Allen, CDC
    Torti, SV
    Torti, FM
    Cyster, JG
    Chen, CY
    Brodsky, FM
    Niemi, EC
    Nakamura, MC
    Seaman, WE
    Daws, MR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (07) : 955 - 965
  • [30] Neuroferritinopathy in a French family with late onset dominant dystonia -: art. no. e69
    Chinnery, PF
    Curtis, ARJ
    Fey, C
    Coulthard, A
    Crompton, D
    Curtis, A
    Lombès, A
    Burn, J
    [J]. JOURNAL OF MEDICAL GENETICS, 2003, 40 (05) : e69